GlassScriptPhysician profile
Jason Arthur Walker
NPI 1326739087
$2,764.41
in general payments reported to CMS, 2019-2025
28 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $613 · 2024: $1,807 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,696 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,696.41 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $565.75 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $350.97 | 2023-2024 | Breztri, Airsupra, Farxiga |
| Axsome Therapeutics, INC. | $270.53 | 2023-2024 | Auvelity |
| Astellas Pharma US INC | $250.32 | 2023-2025 | Veozah |
| Novo Nordisk INC | $222.98 | 2024 | Wegovy, Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $159.41 | 2024 | Xifaxan |
| Lexicon Pharmaceuticals, INC. | $121.14 | 2024 | Inpefa |
| Endo USA, INC. | $96.00 | 2025 | Xiaflex |
| Sanofi-Aventis U.S. LLC | $81.25 | 2023 | |
| Insulet Corporation | $80.00 | 2023 | Omnipod |
| Urogen Pharma, INC. | $63.30 | 2025 | |
| Corium, LLC | $54.49 | 2023-2024 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $49.77 | 2024 | |
| Amneal Pharmaceuticals LLC | $46.36 | 2023-2024 | Unithroid |
| Recordati_rare_diseases_inc. | $45.24 | 2023 | Signifor Lar, Isturisa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $38.56 | 2023 | Afrezza |
| Exact Sciences Corporation | $36.56 | 2023-2024 | Cologuard Collection Kit |
| Laborie Medical Technologies Corp. | $32.66 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Phathom Pharmaceuticals, INC. | $27.66 | 2024 | Voquezna |
| Dentsply Ih Ab | $24.28 | 2025 | Lofric |
| Novartis Pharmaceuticals Corporation | $23.33 | 2025 | |
| Shield Therapeutics INC | $23.21 | 2024 | |
| Sumitomo Pharma America, INC. | $22.17 | 2024 | Gemtesa |
| Teleflex LLC | $19.60 | 2025 | Barrigel |
| Pfizer INC. | $17.40 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.77 | 2023 | Jardiance |
| Lilly USA, LLC | $14.78 | 2024 | Jardiance, Zepbound |
| Mayne Pharma Commercial LLC | $9.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.